Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print January 30, 2008, 10.1148/radiol.2463062200
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2463062200v1
246/3/935    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Best, A. C.
Right arrow Articles by Lynch, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Best, A. C.
Right arrow Articles by Lynch, D. A.
(Radiology 2008;246:935-940.)
© RSNA, 2008


Thoracic Imaging

Idiopathic Pulmonary Fibrosis: Physiologic Tests, Quantitative CT Indexes, and CT Visual Scores as Predictors of Mortality1

Alan C. Best, MD, MS, Jiangfeng Meng, MD, MPH, Anne M. Lynch, MD, MSPH, Carmen M. Bozic, MD, David Miller, PhD, Gary K. Grunwald, PhD, and David A. Lynch, MD

1 From the Departments of Radiology (A.C.B., D.M.), Obstetrics and Gynecology (A.M.L.), and Preventive Medicine and Biometrics (G.K.G.), University of Colorado Denver, 4200 E 9th Ave, Denver, CO 80262; Pediatric Immunology Research Department, Children's Mercy Hospital, Kansas City, Mo (J.M.); Biogen, Cambridge, Mass (C.M.B.); and Division of Radiology, National Jewish Medical and Research Center, Denver, Colo (D.A.L.). Received December 29, 2006; revision requested March 1, 2007; revision received May 14; final version accepted August 13. Supported by Biogen. Address correspondence to A.C.B. (e-mail: alan.best{at}uchsc.edu).

Purpose: To retrospectively evaluate quantitative computed tomographic (CT) indexes, pulmonary function test results, and visual CT scoring as predictors of mortality and to describe serial changes in quantitative CT indexes over 12 months in patients with idiopathic pulmonary fibrosis (IPF).

Materials and Methods: Institutional review board approval and informed consent were obtained at all participating institutions. One hundred sixty-seven patients (110 men, 57 women; mean age, 63 years ± 9 [standard deviation]) with IPF were enrolled in a clinical trial. Patients underwent thin-section CT in the supine position at full inspiration at enrollment (baseline) and at 12-month follow-up. After segmentation of the lungs, mean lung attenuation (MLA), skewness, and kurtosis were measured. Extent of ground glass opacity and lung fibrosis were assessed visually. Forced vital capacity (FVC) and total lung capacity (TLC) were measured. Median duration of follow-up for mortality was 1.5 years. Univariate and multivariate survival analyses were used to determine the predictive value of baseline variables for survival.

Results: At univariate analysis, baseline variables predictive of death included TLC, fibrosis, skewness, and kurtosis. At multivariate analysis, FVC (P = .006) and fibrosis (P = .002) were predictors of short-term mortality. In 95 patients who had both baseline and follow-up CT scans, fibrosis (P = .030), MLA (P = .003), skewness (P < .001), and kurtosis (P < .001) all showed change indicating disease progression.

Conclusion: Visually determined disease extent on CT images is a strong independent predictor of mortality in IPF. Serial evaluation of quantitative CT measures can show disease progression in these patients.

© RSNA, 2008




This article has been cited by other articles:


Home page
JNMHome page
A. M. Groves, T. Win, N. J. Screaton, M. Berovic, R. Endozo, H. Booth, I. Kayani, L. J. Menezes, J. C. Dickson, and P. J. Ell
Idiopathic Pulmonary Fibrosis and Diffuse Parenchymal Lung Disease: Implications from Initial Experience with 18F-FDG PET/CT
J. Nucl. Med., April 1, 2009; 50(4): 538 - 545.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. Behr and V. J. Thannickal
Update in Diffuse Parenchymal Lung Disease 2008
Am. J. Respir. Crit. Care Med., March 15, 2009; 179(6): 439 - 444.
[Full Text] [PDF]


Home page
Ther Adv Respir DisHome page
R. Kim and K. C. Meyer
Review: Therapies for interstitial lung disease: past, present and future
Therapeutic Advances in Respiratory Disease, October 1, 2008; 2(5): 319 - 338.
[Abstract] [PDF]